Pages that link to "Q34076526"
Jump to navigation
Jump to search
The following pages link to TGF-beta utilizes SMAD3 to inhibit CD16-mediated IFN-gamma production and antibody-dependent cellular cytotoxicity in human NK cells (Q34076526):
Displaying 50 items.
- Role of complement and NK cells in antibody mediated rejection (Q26864255) (← links)
- The wound healing, chronic fibrosis, and cancer progression triad (Q27014616) (← links)
- TGF-β signaling and its targeting for glioma treatment (Q28082042) (← links)
- IL-37 is a fundamental inhibitor of innate immunity (Q28295265) (← links)
- Synergistic enhancement of CD8+ T cell-mediated tumor vaccine efficacy by an anti-transforming growth factor-beta monoclonal antibody (Q33581597) (← links)
- Metastatic melanomas express inhibitory low affinity fc gamma receptor and escape humoral immunity (Q34002125) (← links)
- Human tumour immune evasion via TGF-β blocks NK cell activation but not survival allowing therapeutic restoration of anti-tumour activity (Q34016504) (← links)
- Role of interleukin-10 in the regulation of tumorigenicity of a T cell lymphoma (Q34145196) (← links)
- TGFβ in T cell biology and tumor immunity: Angel or devil? (Q34276027) (← links)
- IL-2-activated haploidentical NK cells restore NKG2D-mediated NK-cell cytotoxicity in neuroblastoma patients by scavenging of plasma MICA. (Q34625042) (← links)
- The PP2A inhibitor SET regulates granzyme B expression in human natural killer cells. (Q34707593) (← links)
- TGF-β affects development and differentiation of human natural killer cell subsets (Q34735556) (← links)
- Oral delivery of a probiotic induced changes at the nasal mucosa of seasonal allergic rhinitis subjects after local allergen challenge: a randomised clinical trial (Q35048083) (← links)
- Ex vivo-expanded natural killer cells demonstrate robust proliferation in vivo in high-risk relapsed multiple myeloma patients (Q35157421) (← links)
- Blast-derived microvesicles in sera from patients with acute myeloid leukemia suppress natural killer cell function via membrane-associated transforming growth factor-beta1. (Q35193728) (← links)
- Mechanisms of Trastuzumab resistance in ErbB2-driven breast cancer and newer opportunities to overcome therapy resistance (Q35624814) (← links)
- Dysregulation of serum gamma interferon levels in vascular chronic Q Fever patients provides insights into disease pathogenesis. (Q35656671) (← links)
- CTLA-4⁺ Regulatory T Cells Increased in Cetuximab-Treated Head and Neck Cancer Patients Suppress NK Cell Cytotoxicity and Correlate with Poor Prognosis (Q35674757) (← links)
- Deciphering the Multifaceted Relationship between Oncolytic Viruses and Natural Killer Cells (Q35687743) (← links)
- CD56(bright)CD25+ NK cells are preferentially recruited to the maternal/fetal interface in early human pregnancy (Q36302829) (← links)
- The TGF-β/SMAD pathway is an important mechanism for NK cell immune evasion in childhood B-acute lymphoblastic leukemia (Q36772346) (← links)
- Inhibition of TGF-β enhances the in vivo antitumor efficacy of EGF receptor-targeted therapy (Q36806950) (← links)
- Immunology and immunotherapy of neuroblastoma (Q36856798) (← links)
- A novel pathway of chronic allograft rejection mediated by NK cells and alloantibody (Q36887068) (← links)
- Protective and therapeutic potency of N-acetyl-cysteine on propionic acid-induced biochemical autistic features in rats (Q36922396) (← links)
- Effects of interleukin-18 on natural killer cells: costimulation of activation through Fc receptors for immunoglobulin (Q37000481) (← links)
- IRX-2, a novel immunotherapeutic, enhances and protects NK-cell functions in cancer patients (Q37040481) (← links)
- Differentiation and functional regulation of human fetal NK cells (Q37123919) (← links)
- Dichotomous role of interferon-gamma in allogeneic bone marrow transplant (Q37435506) (← links)
- The polarization of immune cells in the tumour environment by TGFbeta (Q37454364) (← links)
- Lenalidomide overcomes suppression of human natural killer cell anti-tumor functions by neuroblastoma microenvironment-associated IL-6 and TGFβ1. (Q37535365) (← links)
- TGF-β-inducible microRNA-183 silences tumor-associated natural killer cells. (Q37659765) (← links)
- Plasma exosomes as markers of therapeutic response in patients with acute myeloid leukemia (Q37707433) (← links)
- Transcriptional control of natural killer cell differentiation and function. (Q37921660) (← links)
- The role of natural killer cells in immunity against multiple myeloma (Q37994234) (← links)
- Regulation of mouse NK cell development and function by cytokines (Q38174605) (← links)
- Blocking the CCL2-CCR2 Axis Using CCL2-Neutralizing Antibody Is an Effective Therapy for Hepatocellular Cancer in a Mouse Model. (Q38726039) (← links)
- PGC-1α-Dependent Mitochondrial Adaptation Is Necessary to Sustain IL-2-Induced Activities in Human NK Cells. (Q38758270) (← links)
- The TGF-β-inducible miR-23a cluster attenuates IFN-γ levels and antigen-specific cytotoxicity in human CD8⁺ T cells (Q38974828) (← links)
- KRAS mutation confers resistance to antibody-dependent cellular cytotoxicity of cetuximab against human colorectal cancer cells (Q39077167) (← links)
- Antibody-dependent cell cytotoxicity: immunotherapy strategies enhancing effector NK cells. (Q39110347) (← links)
- Comparative assessment of clinically utilized CD20-directed antibodies in chronic lymphocytic leukemia cells reveals divergent NK cell, monocyte, and macrophage properties (Q39192585) (← links)
- Prognostic implication of CD57, CD16, and TGF-β expression in oral squamous cell carcinoma. (Q41161716) (← links)
- Smad3 promotes cancer progression by inhibiting E4BP4-mediated NK cell development (Q42317402) (← links)
- Regulation of mTOR, Metabolic Fitness, and Effector Functions by Cytokines in Natural Killer Cells. (Q43166710) (← links)
- The Role of Transforming Growth Factor Beta-1 in the Progression of HIV/AIDS and Development of Non-AIDS-Defining Fibrotic Disorders (Q45783074) (← links)
- Rationale for combination of therapeutic antibodies targeting tumor cells and immune checkpoint receptors: Harnessing innate and adaptive immunity through IgG1 isotype immune effector stimulation (Q46113809) (← links)
- TGFβR1 Blockade with Galunisertib (LY2157299) Enhances Anti-Neuroblastoma Activity of the Anti-GD2 Antibody Dinutuximab (ch14.18) with Natural Killer Cells (Q46462751) (← links)
- An IL-15 superagonist/IL-15Rα fusion complex protects and rescues NK cell-cytotoxic function from TGF-β1-mediated immunosuppression. (Q48119165) (← links)
- Immunopathogenesis and immunotherapy of multiple myeloma. (Q48169937) (← links)